Biohaven Ltd. logo BHVN - Biohaven Ltd.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 18
HOLD 7
SELL 0
STRONG
SELL
0
| PRICE TARGET: $17.60 DETAILS
HIGH: $23.00
LOW: $10.00
MEDIAN: $18.00
CONSENSUS: $17.60
UPSIDE: 86.24%

Institutional Holders (13F)

GURU SHARES VALUE WEIGHT % SHARES CHG ACTION
Cooperman 2,847,193 $24.1M 0.0% +2,802,093 INCREASED
Wood 373,099 $3.2M 0.0% +168,299 INCREASED
Dalio 0 $0 -- -- SOLD

Insider Trading

BUYS (12M) 5
SELLS (12M) 0
BUY VALUE $31.5M
SELL VALUE $0
DATE INSIDER TITLE TYPE SHARES PRICE VALUE
2026-04-28 HUGIN ROBERT J director A-Award 68,693 $9.61 $660K
2026-04-28 Mehta Kishan director A-Award 68,693 $9.61 $660K
2026-04-28 Bailey Gregory director A-Award 68,693 $9.61 $660K
2026-04-28 Heffernan Michael Thomas director A-Award 68,693 $9.61 $660K
2026-04-28 CHILDS JOHN W director A-Award 68,693 $9.61 $660K
2026-04-28 Antonijevic Irina director A-Award 68,693 $9.61 $660K
2026-04-28 GREGORY JULIA P director A-Award 68,693 $9.61 $660K
2026-03-17 Mehta Kishan director G-Gift 17,342 -- --
2025-03-04 CHILDS JOHN W director BUY 28,400 $30.43 $864K
2026-02-27 Coric Vlad director, officer: Chief Executive Officer A-Award 550,000 $11.52 $6.3M
2026-02-27 Car Bruce officer: Chief Scientific Officer A-Award 175,000 $11.52 $2.0M
2026-02-27 Buten Matthew officer: Chief Financial Officer A-Award 175,000 $11.52 $2.0M
2026-02-27 Gentile Kimberly officer: SVP, Clinical Operations A-Award 175,000 $11.52 $2.0M
2026-02-27 Clark George C. officer: VP, Chief Accounting Officer A-Award 50,000 $11.52 $576K
2026-01-05 Coric Vlad director, officer: Chief Executive Officer F-InKind 7,430 $9.93 $74K
2026-01-05 Coric Vlad director, officer: Chief Executive Officer M-Exempt 14,250 -- --
2026-01-05 Clark George C. officer: VP, Chief Accounting Officer F-InKind 1,117 $9.93 $11K
2026-01-05 Car Bruce officer: Chief Scientific Officer M-Exempt 4,750 -- --
2026-01-05 Gentile Kimberly officer: SVP, Clinical Operations M-Exempt 3,750 -- --
2026-01-05 Car Bruce officer: Chief Scientific Officer F-InKind 2,381 $9.93 $24K
2026-01-05 Gentile Kimberly officer: SVP, Clinical Operations F-InKind 1,956 $9.93 $19K
2026-01-05 Clark George C. officer: VP, Chief Accounting Officer M-Exempt 2,500 -- --
2026-01-05 Buten Matthew officer: Chief Financial Officer M-Exempt 4,250 -- --
2026-01-05 Buten Matthew officer: Chief Financial Officer F-InKind 2,594 $9.93 $26K
2025-11-17 Clark George C. officer: VP, Chief Accounting Officer BUY 17,000 $8.52 $145K

Congressional Trading

No congressional trading data for BHVN.